ArticleNucleic acids research2022

Discovery of potent and versatile CRISPR-Cas9 inhibitors engineered for chemically controllable genome editing.

Guoxu Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.